14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.91 $5.91 Wednesday, 17th Aug 2022 EDGE stock ended at $5.91. During the day the stock fluctuated 0% from a day low at $5.91 to a day high of $5.91.
90 days $5.91 $5.91
52 weeks $4.60 $17.85

Historical Edge Therapeutics prices

Date Open High Low Close Volume
Aug 17, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 16, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 15, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 12, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 11, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 10, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 09, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 08, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 05, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 04, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 03, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 02, 2022 $5.91 $5.91 $5.91 $5.91 0
Aug 01, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 29, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 28, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 27, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 26, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 25, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 22, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 21, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 20, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 19, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 18, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 15, 2022 $5.91 $5.91 $5.91 $5.91 0
Jul 14, 2022 $5.91 $5.91 $5.91 $5.91 0
Click to get the best stock tips daily for free!

About Edge Therapeutics

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. ... EDGE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT